vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.

Simpson Manufacturing Co., Inc. is the larger business by last-quarter revenue ($588.0M vs $487.7M, roughly 1.2× CLOVER HEALTH INVESTMENTS, CORP.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs -10.1%, a 25.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 9.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -0.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.

CLOV vs SSD — Head-to-Head

Bigger by revenue
SSD
SSD
1.2× larger
SSD
$588.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+35.6% gap
CLOV
44.7%
9.1%
SSD
Higher net margin
SSD
SSD
25.1% more per $
SSD
15.0%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-0.8%
SSD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
SSD
SSD
Revenue
$487.7M
$588.0M
Net Profit
$-49.3M
$88.2M
Gross Margin
45.2%
Operating Margin
-10.1%
19.5%
Net Margin
-10.1%
15.0%
Revenue YoY
44.7%
9.1%
Net Profit YoY
-123.2%
13.3%
EPS (diluted)
$2.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SSD
SSD
Q1 26
$588.0M
Q4 25
$487.7M
$539.3M
Q3 25
$496.6M
$623.5M
Q2 25
$477.6M
$631.1M
Q1 25
$462.3M
$538.9M
Q4 24
$337.0M
$517.4M
Q3 24
$331.0M
$587.2M
Q2 24
$356.3M
$597.0M
Net Profit
CLOV
CLOV
SSD
SSD
Q1 26
$88.2M
Q4 25
$-49.3M
$56.2M
Q3 25
$-24.4M
$107.4M
Q2 25
$-10.6M
$103.5M
Q1 25
$-1.3M
$77.9M
Q4 24
$-22.1M
$55.4M
Q3 24
$-9.2M
$93.5M
Q2 24
$7.4M
$97.8M
Gross Margin
CLOV
CLOV
SSD
SSD
Q1 26
45.2%
Q4 25
43.4%
Q3 25
46.4%
Q2 25
46.7%
Q1 25
46.8%
Q4 24
44.0%
Q3 24
24.5%
46.8%
Q2 24
30.3%
46.7%
Operating Margin
CLOV
CLOV
SSD
SSD
Q1 26
19.5%
Q4 25
-10.1%
13.9%
Q3 25
-4.9%
22.6%
Q2 25
-2.2%
22.2%
Q1 25
-0.3%
19.0%
Q4 24
-6.4%
14.8%
Q3 24
-2.7%
21.3%
Q2 24
2.0%
22.1%
Net Margin
CLOV
CLOV
SSD
SSD
Q1 26
15.0%
Q4 25
-10.1%
10.4%
Q3 25
-4.9%
17.2%
Q2 25
-2.2%
16.4%
Q1 25
-0.3%
14.5%
Q4 24
-6.6%
10.7%
Q3 24
-2.8%
15.9%
Q2 24
2.1%
16.4%
EPS (diluted)
CLOV
CLOV
SSD
SSD
Q1 26
$2.13
Q4 25
$1.34
Q3 25
$2.58
Q2 25
$2.47
Q1 25
$1.85
Q4 24
$1.31
Q3 24
$2.21
Q2 24
$2.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SSD
SSD
Cash + ST InvestmentsLiquidity on hand
$78.3M
$341.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$2.1B
Total Assets
$541.0M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SSD
SSD
Q1 26
$341.0M
Q4 25
$78.3M
$384.1M
Q3 25
$297.3M
Q2 25
$190.4M
Q1 25
$150.3M
Q4 24
$194.5M
$239.4M
Q3 24
$288.0M
$339.4M
Q2 24
$254.8M
$354.9M
Total Debt
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
$300.0M
Q3 25
$371.3M
Q2 25
$376.9M
Q1 25
$382.5M
Q4 24
$388.1M
Q3 24
$393.8M
Q2 24
$399.4M
Stockholders' Equity
CLOV
CLOV
SSD
SSD
Q1 26
$2.1B
Q4 25
$308.7M
$2.0B
Q3 25
$340.9M
$2.0B
Q2 25
$344.2M
$1.9B
Q1 25
$336.1M
$1.9B
Q4 24
$341.1M
$1.8B
Q3 24
$342.2M
$1.9B
Q2 24
$324.9M
$1.8B
Total Assets
CLOV
CLOV
SSD
SSD
Q1 26
$3.0B
Q4 25
$541.0M
$3.1B
Q3 25
$559.7M
$3.0B
Q2 25
$575.0M
$3.0B
Q1 25
$583.7M
$2.8B
Q4 24
$580.7M
$2.7B
Q3 24
$653.0M
$2.9B
Q2 24
$674.2M
$2.8B
Debt / Equity
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
0.15×
Q3 25
0.19×
Q2 25
0.20×
Q1 25
0.21×
Q4 24
0.21×
Q3 24
0.21×
Q2 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SSD
SSD
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
$-66.9M
$155.7M
Q3 25
$12.1M
$170.2M
Q2 25
$5.4M
$125.2M
Q1 25
$-16.3M
$7.6M
Q4 24
$34.8M
$115.8M
Q3 24
$50.0M
$103.3M
Q2 24
$44.8M
$111.1M
Free Cash Flow
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
$-69.0M
$119.0M
Q3 25
$11.4M
$133.9M
Q2 25
$4.8M
$87.3M
Q1 25
$-16.5M
$-42.6M
Q4 24
$33.3M
$60.3M
Q3 24
$49.6M
$58.1M
Q2 24
$44.4M
$70.9M
FCF Margin
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
-14.1%
22.1%
Q3 25
2.3%
21.5%
Q2 25
1.0%
13.8%
Q1 25
-3.6%
-7.9%
Q4 24
9.9%
11.7%
Q3 24
15.0%
9.9%
Q2 24
12.5%
11.9%
Capex Intensity
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
0.4%
6.8%
Q3 25
0.1%
5.8%
Q2 25
0.1%
6.0%
Q1 25
0.0%
9.3%
Q4 24
0.5%
10.7%
Q3 24
0.1%
7.7%
Q2 24
0.1%
6.7%
Cash Conversion
CLOV
CLOV
SSD
SSD
Q1 26
Q4 25
2.77×
Q3 25
1.58×
Q2 25
1.21×
Q1 25
0.10×
Q4 24
2.09×
Q3 24
1.10×
Q2 24
6.04×
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons